CYH33-induced hyperglycemia

1 paper studies it1 finding

Animals1

Interventions

1

Dapagliflozin

downin mice1

1 study

Dapagliflozin decreases CYH33-induced hyperglycemia in mice.
“dapagliflozin effectively alleviated CYH33-induced hyperglycemia while preserving its antitumor activity in T1D mice.”
Animalstype 1 diabetic mice treated with CYH33
Dapagliflozin alleviates CYH33-induced hyperglycemia and preserves antitumor immunity against ovarian cancer in type 1 diabetic mice
Life sciencesOct 17, 2026

More on Dapagliflozin

Latest

1 paper in 12 months

Life SciencesOct 18

Dapagliflozin alleviates CYH33-induced hyperglycemia and preserves antitumor immunity against ovarian cancer in type 1 diabetic mice

Experiments in miceDapagliflozin